ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Nexalin Technologies Inc

Nexalin Technologies Inc (NXL)

1.3606
-0.0694
( -4.85% )
Updated: 05:47:29

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
1.3606
Bid
1.36
Offer
1.37
Volume
171,466
1.331 Day's Range 1.46
0.2528 52 Week Range 4.05
Market Cap
Previous Close
1.43
Open
1.43
Last Trade
4
@
1.36
Last Trade Time
05:47:29
Financial Volume
US$ 238,543
VWAP
1.3912
Average Volume (3m)
2,974,950
Shares Outstanding
7,436,562
Dividend Yield
-
PE Ratio
-2.18
Earnings Per Share (EPS)
-0.63
Revenue
111k
Net Profit
-4.65M

About Nexalin Technologies Inc

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Nexalin Technologies Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker NXL. The last closing price for Nexalin Technologies was US$1.43. Over the last year, Nexalin Technologies shares have traded in a share price range of US$ 0.2528 to US$ 4.05.

Nexalin Technologies currently has 7,436,562 shares in issue. The market capitalisation of Nexalin Technologies is US$10.63 million. Nexalin Technologies has a price to earnings ratio (PE ratio) of -2.18.

NXL Latest News

Nexalin Technology Announces Closing of $5.2 Million Public Offering

HOUSTON, TX, July 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced the closing of its previously announced public offering...

Nexalin Technology Announces Pricing of $5.2 Million Public Offering

HOUSTON, TX, June 27, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced the pricing of a public offering of 3,000,000 shares of...

Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal

Study demonstrates strong statistical separation between patients receiving Nexalin’s DIFS® technology in combination with escitalopram (Lexapro) vs sham group receiving escitalopram alone...

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office...

Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

HOUSTON, TX, June 13, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA...

Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th

HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap...

FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1494-9.89403973511.511.63991.3313638961.42644294CS
40.09067.133858267721.274.05183602721.99112714CS
12-0.2494-15.49068322981.614.050.5329749501.86718548CS
260.9804257.8642819570.38024.050.252817534361.76931113CS
520.5363.80929448590.83064.050.25288893501.73437147CS
156-1.3394-49.60740740742.74.050.25285470421.70203454CS
260-1.3394-49.60740740742.74.050.25285470421.70203454CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMBCambium Bio Ltd
AUD 0.40
(9,900.00%)
2k
LRLLabyrinth Resources Ltd
AUD 0.015
(200.00%)
42.23M
VPRVolt Group Ltd
AUD 0.002
(100.00%)
343.18k
TD1Tali Digital Limited
AUD 0.0015
(50.00%)
10k
PRXProdigy Gold NL
AUD 0.003
(50.00%)
1.47M
RHYORhythm Biosciences Limited
AUD 0.005
(-75.00%)
916
JTLJayex Technology Limited
AUD 0.001
(-50.00%)
1.34M
EDEEden Innovations Ltd
AUD 0.001
(-50.00%)
79k
DTIDTI Group Limited
AUD 0.009
(-35.71%)
4.16k
SI6Si6 Metals Limited
AUD 0.002
(-33.33%)
2.8M
ATHAlterity Therapeutics Ltd
AUD 0.007
(40.00%)
154.34M
AMDArrow Minerals Limited
AUD 0.003
(20.00%)
123.6M
FBRFBR Limited
AUD 0.05
(4.17%)
64.55M
MRQOMRG Metals Limited
AUD 0.001
(0.00%)
43.5M
LRLLabyrinth Resources Ltd
AUD 0.015
(200.00%)
42.23M

NXL Discussion

View Posts
Bigspirit1 Bigspirit1 6 days ago
okay I was wrong re the short sellers. The longer view is for a much higher valuation
👍️0
Bigspirit1 Bigspirit1 2 weeks ago
The short sellers will pay the price. Stock is headed way up
👍️0
Bigspirit1 Bigspirit1 2 weeks ago
The short sellers will pay the price. Stock is headed way up
👍️0
Runners123 Runners123 2 weeks ago
NXL Specific Mentions on reddit
As of Jul 3, 2024 12:41:37 PM EDT (
👍️0
Runners123 Runners123 2 weeks ago
NXL is going to rile up drug pharma and could get bought to keep out of the market which is sooooo profitable for pharma. The insomnia, anxiety, depression drug sales is in the half a trillion dollars arena.
👍️0
al dean al dean 3 weeks ago
Public Offering announced late Thursday. 3 million shares will be added. Pre market will be crazy
👍️0
Awl416 Awl416 3 weeks ago
Crazy
👍️0
glenn1919 glenn1919 3 weeks ago
NXL............https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936
👍️0
Golden Cross Golden Cross 4 weeks ago
$3+ soon🛫
💩 1 🤡 1
StockItOut StockItOut 4 weeks ago
Yet another after-the-breakout post by @Zardiw #DDAmanda.

Your video, you say, "there's an entry here because there's something going on with this stock."

Yet, you say so having the 'advantage' of Monday morning quarterbacking. You have the advantage of once only after you've done your scan you then are able to look and call out previous days' trading activity to claim you did a scsn previously... when you did not.

If you did, where was your previous DDAmanda post then that showed the activity, and that shows what you now after-the-breakout call, "there's an entry here because there's something going on with this stock."

Seems you're a bullshitter (a low level) scammer trying to trick people into purchasing your wwwaaaayyyy over priced $2,400 per year #DDAmanda software from a team of "we" (as you always say) that in actuality as a "we" in only you.

.
👍️0
Zardiw Zardiw 4 weeks ago
$NXL +211% #DDAmanda Video Analysis

#1 Stock Scanner/Screener



Z
👍️0
mcnierney1 mcnierney1 4 weeks ago
thanks
👍️0
Invest-in-America Invest-in-America 4 weeks ago
NXL: "This is one GREAT LEAP for the trading account of iHub's mcnierney1 Fellow --- but one TINY STEP for the rest of iHub'ers everywhere!! HOUSTON, do you copy!!"
👍️ 1
mcnierney1 mcnierney1 4 weeks ago
yes its awesome just the start
👍️0
Invest-in-America Invest-in-America 4 weeks ago
NXL: Well then, Dude, tell us all what it's LIKE up there!!! (I missed this one ENTIRELY!!)
👍️0
Invest-in-America Invest-in-America 4 weeks ago
NXL: What-the-FLUCK??!!! (Rather LATE price reaction to their yesterday PR!!)
👍️0
Awl416 Awl416 4 weeks ago
Crazy volume
👍️0
glenn1919 glenn1919 4 weeks ago
NXL..........https://stockcharts.com/h-sc/ui?s=NXL&p=W&b=5&g=0&id=p86431144783
👍️0
mcnierney1 mcnierney1 4 weeks ago
getting prepared to go to the moon only a foolish investor would not think so!
👍️0
mcnierney1 mcnierney1 4 weeks ago
Strong buy this will triple in my opinion
👍️0
Invest-in-America Invest-in-America 4 weeks ago
NXL: Could you please ELABORATE a little beyond simply, "DAMN"???
👍️0
Awl416 Awl416 4 weeks ago
Damn
👍️0
mcnierney1 mcnierney1 4 weeks ago
strong buy!! So many mental health disorders will be helped and tbi will be helped
👍️0
GhosTraderX GhosTraderX 1 month ago
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Source: GlobeNewswire Inc.?

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation device has been granted regulatory approval by the Brazilian Health Regulatory Agency, a regulatory body of the Brazilian government responsible for approving new drugs and medical devices.
Mark White, CEO of Nexalin Technology, stated, "We are pleased to announce approval to sell our Gen-2 neurostimulation device in Brazil, which represents our second regulatory approval outside of China since the start of this year.  Brazil is an important market as it represents the 9th largest economy in the world with a population in excess of 215 million.  Among this population, more than 35 million are afflicted with mental health disorders. Moreover, this approval is an important springboard into other markets within South America.  We are rapidly advancing discussions with a key distributor in this market and look forward to providing further updates.”
About Nexalin Technology, Inc.
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device was recently approved in Oman and China.  Additional information about the Company is available at: https://nexalin.com/.
FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute "forward-looking statements," These statements relate to future events or Nexalin’s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that Nexalin or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or Nexalin’s actual results to differ materially from those indicated by the forward-looking statements.  Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's Report on Form 10-K for the year ended December 31, 2023 and other filings as filed with the Securities and Exchange Commission. Copies of such filings are available on the SEC's website, www.sec.gov. Such forward-looking statements are made as of the date hereof and may become outdated over time. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: NXL@crescendo-ir.com
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
NXL@redchip.com
👍️0
Awl416 Awl416 3 months ago
Yikes
👍️0
bikaver bikaver 3 months ago
NXL...grabbed a few @ 2.38
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
lol
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: I do get in my CLOWN moods, occasionally. (Right now, I have to CHANGE my iHub Profile Picture --- to reflect my TRUE inner spirit!!!)
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: HA-HAAAAA!!! Why not???
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: Hey, and THANKS again for the selfie video clip of YOU (below), working your latest "AI-MARKETS-SCANNER"!!!


"I see a price CORRECTION looming in precisely 15-seconds on NXL --- prepare to abort the play!!! And reload to FLIP-IT again!!!"
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
I MAY NEED TO USE ONE OF THEIR HEAD BANDS FOR TAKING THIS OFF MY SCREEN
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
LOL..YOU MAKE ME LAUGH DUDE
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: Hey, Dude, I FOLLOW your posts everyday --- like a Police Dog on a short leash!!!
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
MARKET CORRECTION IS HERE
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
LMAO...LUV YOU DUDE...CAN'T BELIEVE I WAS THE FIRST HERE AND FIRST TO GO....IDIOT I AM!
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: Hey there, Lord T-T-2016, Dude!!! What-the-fluck is goin' on today, Homeboy --- across the Wall Street MARKETOS!!!

PS: The LEAD GUITAR RIFT in that Pat Benetar song is OFF-THE-SPECTRUM, Bro!! That guitar dude hits a NOTE therein that is from another GALAXY!!!


(Let the above run, until that LEAD GUITAR does his stuff!!!)
👍️0
TrendTrade2016 TrendTrade2016 3 months ago
LMAO...FLEET COMANDO!!!!
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: This is the Fleet Commander to all NXL Company warships --- FIRE-AT-WILL!!!



👍️0
Invest-in-America Invest-in-America 3 months ago
Nope, that monster number there was NOT me dumping my @VVPR --- but that WAS an easy & quick flip, for my little (late Pre-M) 'Lotto Ticket' behind it.
👍️0
TIMGZ TIMGZ 3 months ago
VVPR
👍️0
Invest-in-America Invest-in-America 3 months ago
Not sure WHICH stock you are referring to, Capt. TIm.
👍️0
TIMGZ TIMGZ 3 months ago
2M FLOAT,LOOK AT THE BIG DUMP***18M ONE TIME, THATMUSTBEYOU
👍️0
Invest-in-America Invest-in-America 3 months ago
@AINC merely the old ploy, 'We ain't gonna dump more shares on ya, America, so make our stock SOAR now!!' (And @VVPR a nice quip FLIP, right out the starting gate today, Dude!!!)
👍️0
TIMGZ TIMGZ 3 months ago
ADTX,VVPR, AINC e.t.c
👍️0
Invest-in-America Invest-in-America 3 months ago
NXL: Told ya so!!!! To dah MOON!!!
👍️0
Invest-in-America Invest-in-America 4 months ago
NXL: Watch out!! They gots some BONKERS Electromagnetic GADGETS at the NXL Firm!!! (See ME, below, using one their disruptive new "Post-Traumatic-STUPIDITY-Disorder", deep-Brain, stimulators during routine brushing of my teeth!!!)

👍️0
Bigspirit1 Bigspirit1 4 months ago
you were right
👍️0
realtmg realtmg 4 months ago
Closed up 50% … Expecting continuation going north tomorrow… IMO
👍️0
Bigspirit1 Bigspirit1 4 months ago
A real micro beast. The product pipeline is amazing!
👍️0
TrendTrade2016 TrendTrade2016 4 months ago
NXL..THIN....HERE WE GO
👍️0

Your Recent History

Delayed Upgrade Clock